APA (7th ed.) Citation

D, I., Ö, A., G, A., S, Y., O, K., YE, A., . . . N, T. (2024). Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older. Journal of clinical medicine, 13(20), . https://doi.org/10.3390/jcm13206263

Chicago Style (17th ed.) Citation

D, Isik, et al. "Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older." Journal of Clinical Medicine 13, no. 20 (2024). https://doi.org/10.3390/jcm13206263.

MLA (9th ed.) Citation

D, Isik, et al. "Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older." Journal of Clinical Medicine, vol. 13, no. 20, 2024, https://doi.org/10.3390/jcm13206263.